Mimio Health

Harnessing the power of fasting to fight aging and enhance health

Based based in United States, Mimio Health works in consumer bio, founded in 2020.

Profile

Mimio Health (fka Innate Biology) is a nutraceutical company dedicated to the research and production of the world’s first fasting mimetic supplement. Our supplement was designed from clinical research to replicate the cellular health benefits and lifespan-promoting effects of fasting without the need to fast. Through years of research into human fasting we have uncovered a conserved metabolic program for cellular health and regeneration that underpins the beneficial effects of fasting. Our patent-pending fasting mimetic forumuation uses a rigorously selected combination of the same bioactive human metabolites that induce this regenerative “bio-program” to replicate the body’s natural response to fasting without having to fast. We have shown that our fasting mimetic is capable of extending the lifespan of model organisms by 96% and has powerful anti-inflammatory and antioxidant effects in human cells that could combat age-associated chronic inflammation and cellular damage allowing our customers to live longer, healthier lives.

The company sits in the consumer bio segment, where it competes on its core product or service.

The business is associated with United States.

The company is listed at the SOSV portfolio company stage of development.

Recorded headcount: 2-10 employees.

Website: www.mimiohealth.com